Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Universita' Vita-salute S. Raffaele
Sponsor

Universita' Vita-salute S. Raffaele

Italy Via Olgettina 58, 20132 Milan, Italy

About the sponsor

Clinical research in major depressive disorder focuses on treatment-resistant illness and the neurobiological factors linked to response to ketamine and electroconvulsive therapy.

  • treatment-resistant depression
  • ketamine
  • electroconvulsive therapy
  • neurochemical response markers

Work in this area centers on identifying clinical and biological features associated with antidepressant response.

About Specializations

Universita' Vita-salute S. Raffaele runs clinical trials in conditions such as Depression, Breast cancer, Non-small cell lung cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Depression

Recruiting

Study on the Effects of Ketamine and Electroconvulsive Therapy for Patients with Treatment-Resistant Major Depressive Disorder

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Universita' Vita-salute S. Raffaele

Breast cancer

Recruiting

Study on 18F-FES PET/MRI for Patients with Luminal A and Lobular Breast Cancer to Improve Treatment Decisions

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Universita' Vita-salute S. Raffaele

Non-small cell lung cancer

Not yet recruiting

Study of cemiplimab with or without chemotherapy for non-small cell lung cancer patients with high PD-L1 levels to reduce rapid disease progression

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Universita' Vita-salute S. Raffaele

Depression

Not yet recruiting

Study on the Effects of Ketamine and Electroconvulsive Therapy in Patients with Treatment-Resistant Major Depressive Disorder

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Universita' Vita-salute S. Raffaele

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.